Zeta Pharma has been the fastest-growing Egyptian pharmaceutical company during the last four years.  Zeta Pharma had a well selected and unique product portfolio in all therapeutic areas.

Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).

In collaboration with the Egyptian Ministry of Health and Egyptian Liver Research Institute, ZETA PHARMA® has managed to treat more than 60,000 patients with healing rates 95 % similar to those of the global rate.

Our state of art production facility designed to comply with GMP and WHO standards. ZETA PHARMA® also invests in human capital through attracting, cultivating and retaining excellent talents with passionate commitment to ZETA PHARMA’S work ethic and strong core values. Integrating the most cutting-edge science with the best human caliber in the market allows us to serve as a reliable partner in the healthcare system.